Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

A. Michael Lincoff, John A. Bittl, Neal S. Kleiman, Ian J. Sarembock, J. Daniel Jackman, Sameer Mehta, Mark A. Tannenbaum, Alan L. Niederman, William B. Bachinsky, J. Tift-Mann, H. Graham Parker, Dean J. Kereiakes, Robert A. Harrington, Frederick Feit, Elizabeth S. Maierson, Derek P. Chew, Eric J. Topol

Research output: Contribution to journalArticlepeer-review

217 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)'. Together they form a unique fingerprint.

Medicine & Life Sciences